JR-446

DRUG2 trials

Sponsors

JCR Pharmaceuticals Co., Ltd.

Conditions

Mucopolysaccharidosis III-BMucopolysaccharidosis IIIB

Phase 1

An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB

RecruitingNCT06488924

JCR Pharmaceuticals Co., Ltd.Mucopolysaccharidosis III-B

Start: 2024-11-05End: 2030-04-30Target: 10Updated: 2025-09-02

A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)

Not yet recruitingNCT07640984

JCR Pharmaceuticals Co., Ltd.Mucopolysaccharidosis IIIB

Start: 2026-09-09End: 2028-09-30Target: 12Updated: 2026-09-08